| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1B2 MYO1D WRN COQ8B DDX1 DHX8 MDN1 KIF14 ACSBG2 DDX60L ABCC2 ATP2B1 SNRNP200 HSPA4 HELLS | 1.64e-05 | 614 | 134 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.95e-05 | 123 | 134 | 7 | GO:0030165 | |
| GeneOntologyMolecularFunction | nuclease activity | 1.70e-04 | 231 | 134 | 8 | GO:0004518 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | POP4 AGO2 FBL POLG WRN SAMHD1 SLFN14 DDX1 DHX8 DDX60L SNRNP200 EXOSC4 HELLS | 4.07e-04 | 645 | 134 | 13 | GO:0140640 |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | POP4 AGO2 FBL SAMHD1 SLFN14 DDX1 DHX8 DDX60L SNRNP200 EXOSC4 | 5.18e-04 | 417 | 134 | 10 | GO:0140098 |
| GeneOntologyMolecularFunction | eukaryotic translation initiation factor 2alpha kinase activity | 6.59e-04 | 6 | 134 | 2 | GO:0004694 | |
| GeneOntologyMolecularFunction | helicase activity | 6.96e-04 | 158 | 134 | 6 | GO:0004386 | |
| GeneOntologyMolecularFunction | protein domain specific binding | VPS11 MYO1D CIT UBR5 MUC17 SHCBP1 KIF14 PLEKHA1 PLEKHA2 DLG2 TRAK2 ABCC2 CACYBP ATP2B1 SOS1 | 7.94e-04 | 875 | 134 | 15 | GO:0019904 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 7.96e-04 | 441 | 134 | 10 | GO:0016887 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell development | 7.34e-06 | 73 | 132 | 6 | GO:0060119 | |
| GeneOntologyBiologicalProcess | neuron development | PRTG DPYSL2 FAT4 GAK FN1 CDH23 ITGA1 ADGRV1 TECTA USH1C CIT PTPN5 IGF2BP1 EHD1 PLXNA4 KCNQ1 DLG2 ACTL6B TRAK2 SEMA4A FBXO45 TNR NCK2 SOS1 | 1.73e-05 | 1463 | 132 | 24 | GO:0048666 |
| GeneOntologyBiologicalProcess | neuron projection development | PRTG DPYSL2 FAT4 GAK FN1 CDH23 ITGA1 ADGRV1 TECTA USH1C CIT PTPN5 IGF2BP1 EHD1 PLXNA4 ACTL6B TRAK2 SEMA4A FBXO45 TNR NCK2 SOS1 | 2.14e-05 | 1285 | 132 | 22 | GO:0031175 |
| GeneOntologyBiologicalProcess | inner ear receptor cell stereocilium organization | 2.23e-05 | 53 | 132 | 5 | GO:0060122 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 3.55e-05 | 96 | 132 | 6 | GO:0060113 | |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 5.57e-05 | 104 | 132 | 6 | GO:0042490 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation by eIF2 alpha phosphorylation | 1.10e-04 | 15 | 132 | 3 | GO:0010998 | |
| GeneOntologyBiologicalProcess | auditory receptor cell development | 1.23e-04 | 40 | 132 | 4 | GO:0060117 | |
| GeneOntologyCellularComponent | ciliary pocket membrane | 1.22e-04 | 3 | 134 | 2 | GO:0020018 | |
| GeneOntologyCellularComponent | ciliary pocket | 1.22e-04 | 3 | 134 | 2 | GO:0020016 | |
| GeneOntologyCellularComponent | cell body | DPYSL2 MYO1D ITGA1 CIT NMNAT3 PTPN5 IGF2BP1 SLC8A1 LNPEP SKOR1 KCNQ1 DLG2 TRAK2 CACYBP ATP2B1 SOS1 | 3.04e-04 | 929 | 134 | 16 | GO:0044297 |
| GeneOntologyCellularComponent | neuronal cell body | DPYSL2 MYO1D ITGA1 CIT NMNAT3 PTPN5 IGF2BP1 SLC8A1 LNPEP SKOR1 KCNQ1 DLG2 TRAK2 ATP2B1 SOS1 | 3.05e-04 | 835 | 134 | 15 | GO:0043025 |
| GeneOntologyCellularComponent | cell projection membrane | MYO1D PIEZO1 ADGRV1 EHD3 PTPRJ MUC17 EHD1 PLEKHA1 ABCC2 ATP2B1 | 4.70e-04 | 431 | 134 | 10 | GO:0031253 |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 5.97e-04 | 223 | 134 | 7 | GO:0098862 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 6.02e-04 | 6 | 134 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 6.02e-04 | 6 | 134 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | basal part of cell | 7.54e-04 | 378 | 134 | 9 | GO:0045178 | |
| GeneOntologyCellularComponent | somatodendritic compartment | DPYSL2 AGO2 MYO1D ITGA1 CIT NMNAT3 ABHD17C PTPN5 IGF2BP1 SLC8A1 LNPEP SKOR1 KCNQ1 DLG2 TRAK2 PLEC ATP2B1 SOS1 | 8.62e-04 | 1228 | 134 | 18 | GO:0036477 |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.11e-03 | 8 | 134 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 1.12e-03 | 32 | 134 | 3 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 1.12e-03 | 32 | 134 | 3 | GO:0043189 | |
| GeneOntologyCellularComponent | cell leading edge | ATP6V1B2 MYO1D PIEZO1 ADGRV1 CIT IGF2BP1 PTPRJ PLEKHA1 ATP2B1 ARHGEF6 | 1.45e-03 | 500 | 134 | 10 | GO:0031252 |
| GeneOntologyCellularComponent | apical part of cell | ATP6V1B2 FAT4 FN1 CDH23 USH1C CLCN5 MUC17 KCNQ1 PLEC ABCC2 ATP2B1 | 1.52e-03 | 592 | 134 | 11 | GO:0045177 |
| GeneOntologyCellularComponent | perineuronal net | 1.77e-03 | 10 | 134 | 2 | GO:0072534 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | DPYSL2 PTPRT ABHD17C USP6 SLC8A1 PLXNA4 DLG2 FBXO45 TNR NCK2 | 2.02e-03 | 523 | 134 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | basal plasma membrane | 2.05e-03 | 354 | 134 | 8 | GO:0009925 | |
| GeneOntologyCellularComponent | actin-based cell projection | 2.13e-03 | 278 | 134 | 7 | GO:0098858 | |
| GeneOntologyCellularComponent | perisynaptic extracellular matrix | 2.16e-03 | 11 | 134 | 2 | GO:0098966 | |
| MousePheno | abnormal hair cell mechanoelectric transduction | 3.06e-06 | 14 | 107 | 4 | MP:0004431 | |
| MousePheno | abnormal orientation of outer hair cell stereociliary bundles | 3.06e-05 | 24 | 107 | 4 | MP:0004491 | |
| MousePheno | abnormal cochlear hair cell inter-stereocilial links morphology | 3.54e-05 | 9 | 107 | 3 | MP:0004577 | |
| MousePheno | abnormal vitelline vascular remodeling | 1.01e-04 | 61 | 107 | 5 | MP:0004076 | |
| MousePheno | cochlear degeneration | 1.09e-04 | 62 | 107 | 5 | MP:0000032 | |
| MousePheno | cochlear ganglion degeneration | 1.18e-04 | 63 | 107 | 5 | MP:0002857 | |
| MousePheno | head tossing | 1.42e-04 | 35 | 107 | 4 | MP:0005307 | |
| MousePheno | abnormal orientation of cochlear hair cell stereociliary bundles | 1.42e-04 | 35 | 107 | 4 | MP:0004522 | |
| MousePheno | absent atrioventricular cushions | 1.49e-04 | 14 | 107 | 3 | MP:0000298 | |
| Domain | CXorf40 | 5.11e-05 | 2 | 134 | 2 | IPR033615 | |
| Domain | Big_2 | 5.11e-05 | 2 | 134 | 2 | PF02368 | |
| Domain | Invasin/intimin_cell_adhesion | 5.11e-05 | 2 | 134 | 2 | IPR008964 | |
| Domain | BID_2 | 5.11e-05 | 2 | 134 | 2 | SM00635 | |
| Domain | EHD1/EHD3 | 5.11e-05 | 2 | 134 | 2 | IPR029951 | |
| Domain | Big_2 | 5.11e-05 | 2 | 134 | 2 | IPR003343 | |
| Domain | Peptidase_M1_N | 9.80e-05 | 13 | 134 | 3 | IPR014782 | |
| Domain | Peptidase_M1 | 9.80e-05 | 13 | 134 | 3 | PF01433 | |
| Domain | P-loop_NTPase | ATP6V1B2 MYO1D WRN SLFN14 DDX1 DHX8 EHD3 RAB36 GTPBP2 MDN1 EHD1 KIF14 DLG2 DDX60L ABCC2 SNRNP200 HELLS | 1.21e-04 | 848 | 134 | 17 | IPR027417 |
| Domain | Helicase_C | 1.22e-04 | 107 | 134 | 6 | PF00271 | |
| Domain | HELICc | 1.22e-04 | 107 | 134 | 6 | SM00490 | |
| Domain | Helicase_C | 1.28e-04 | 108 | 134 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 1.35e-04 | 109 | 134 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.35e-04 | 109 | 134 | 6 | PS51192 | |
| Domain | DEXDc | 1.35e-04 | 109 | 134 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.42e-04 | 110 | 134 | 6 | IPR014001 | |
| Domain | ASCH_domain | 1.53e-04 | 3 | 134 | 2 | IPR007374 | |
| Domain | ASCH | 1.53e-04 | 3 | 134 | 2 | SM01022 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.79e-04 | 73 | 134 | 5 | IPR011545 | |
| Domain | DEAD | 1.79e-04 | 73 | 134 | 5 | PF00270 | |
| Domain | - | ATP6V1B2 WRN SLFN14 DDX1 DHX8 EHD3 RAB36 GTPBP2 MDN1 EHD1 DLG2 DDX60L ABCC2 SNRNP200 HELLS | 3.02e-04 | 746 | 134 | 15 | 3.40.50.300 |
| Domain | EHD_N | 5.04e-04 | 5 | 134 | 2 | IPR031692 | |
| Domain | EHD_N | 5.04e-04 | 5 | 134 | 2 | PF16880 | |
| Domain | ConA-like_dom | 1.03e-03 | 219 | 134 | 7 | IPR013320 | |
| Domain | Cadherin_CS | 1.13e-03 | 109 | 134 | 5 | IPR020894 | |
| Domain | CADHERIN_1 | 1.33e-03 | 113 | 134 | 5 | PS00232 | |
| Domain | Cadherin | 1.33e-03 | 113 | 134 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 1.39e-03 | 114 | 134 | 5 | PS50268 | |
| Domain | - | 1.39e-03 | 114 | 134 | 5 | 2.60.40.60 | |
| Domain | ERAP1-like_C_dom | 1.39e-03 | 8 | 134 | 2 | IPR024571 | |
| Domain | Calx_beta | 1.39e-03 | 8 | 134 | 2 | SM00237 | |
| Domain | ERAP1_C | 1.39e-03 | 8 | 134 | 2 | PF11838 | |
| Domain | CA | 1.44e-03 | 115 | 134 | 5 | SM00112 | |
| Domain | Cadherin-like | 1.50e-03 | 116 | 134 | 5 | IPR015919 | |
| Domain | Plexin_repeat | 1.54e-03 | 32 | 134 | 3 | IPR002165 | |
| Domain | PSI | 1.54e-03 | 32 | 134 | 3 | PF01437 | |
| Domain | Cadherin | 1.61e-03 | 118 | 134 | 5 | IPR002126 | |
| Domain | Calx_beta | 1.78e-03 | 9 | 134 | 2 | IPR003644 | |
| Domain | Calx-beta | 1.78e-03 | 9 | 134 | 2 | PF03160 | |
| Domain | EGF-like_dom | 2.15e-03 | 249 | 134 | 7 | IPR000742 | |
| Domain | PTPc | 2.17e-03 | 36 | 134 | 3 | SM00194 | |
| Domain | EF-hand_4 | 2.21e-03 | 10 | 134 | 2 | PF12763 | |
| Domain | ZP_dom_CS | 2.21e-03 | 10 | 134 | 2 | IPR017977 | |
| Domain | SH3_9 | 2.40e-03 | 78 | 134 | 4 | PF14604 | |
| Domain | EGF_1 | 2.46e-03 | 255 | 134 | 7 | PS00022 | |
| Domain | EH | 2.69e-03 | 11 | 134 | 2 | PS50031 | |
| Domain | EH | 2.69e-03 | 11 | 134 | 2 | SM00027 | |
| Domain | EH_dom | 2.69e-03 | 11 | 134 | 2 | IPR000261 | |
| Domain | TYR_PHOSPHATASE_PTP | 2.73e-03 | 39 | 134 | 3 | PS50055 | |
| Domain | EGF-like_CS | 2.80e-03 | 261 | 134 | 7 | IPR013032 | |
| Domain | PTPase_domain | 3.15e-03 | 41 | 134 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 3.15e-03 | 41 | 134 | 3 | PF00102 | |
| Domain | Peptidase_M1 | 3.22e-03 | 12 | 134 | 2 | IPR001930 | |
| Domain | PSI | 3.86e-03 | 44 | 134 | 3 | IPR016201 | |
| Domain | - | 4.35e-03 | 92 | 134 | 4 | 3.90.190.10 | |
| Domain | PSI | 4.38e-03 | 46 | 134 | 3 | SM00423 | |
| Domain | G_DYNAMIN_dom | 4.39e-03 | 14 | 134 | 2 | IPR030381 | |
| Domain | ZP_2 | 4.39e-03 | 14 | 134 | 2 | PS51034 | |
| Domain | ZP_1 | 4.39e-03 | 14 | 134 | 2 | PS00682 | |
| Domain | G_DYNAMIN_2 | 4.39e-03 | 14 | 134 | 2 | PS51718 | |
| Domain | - | 4.65e-03 | 47 | 134 | 3 | 3.30.420.10 | |
| Domain | Dynamin_GTPase | 5.05e-03 | 15 | 134 | 2 | IPR001401 | |
| Domain | Dynamin_SF | 5.05e-03 | 15 | 134 | 2 | IPR022812 | |
| Domain | Dynamin_N | 5.05e-03 | 15 | 134 | 2 | PF00350 | |
| Domain | ZP | 5.05e-03 | 15 | 134 | 2 | SM00241 | |
| Domain | Prot-tyrosine_phosphatase-like | 5.64e-03 | 99 | 134 | 4 | IPR029021 | |
| Domain | Actin_CS | 5.74e-03 | 16 | 134 | 2 | IPR004001 | |
| Domain | PH | 6.22e-03 | 229 | 134 | 6 | PF00169 | |
| Domain | fn3 | 6.28e-03 | 162 | 134 | 5 | PF00041 | |
| Domain | ACTINS_2 | 6.48e-03 | 17 | 134 | 2 | PS00432 | |
| Domain | ZP_dom | 6.48e-03 | 17 | 134 | 2 | IPR001507 | |
| Domain | Zona_pellucida | 6.48e-03 | 17 | 134 | 2 | PF00100 | |
| Domain | SH3_1 | 6.61e-03 | 164 | 134 | 5 | PF00018 | |
| Domain | EGF | 7.03e-03 | 235 | 134 | 6 | SM00181 | |
| Domain | EGF_3 | 7.03e-03 | 235 | 134 | 6 | PS50026 | |
| Pubmed | ATP6V1B2 DPYSL2 GAK AGO2 FN1 MYO1D NBEA NDUFA9 CIT DDX1 EHD3 VCAN EHD1 PLXNA4 DLG2 ACTL6B PLEC TNR ATP2B1 SNRNP200 HSPA4 NCK2 | 3.04e-08 | 1431 | 134 | 22 | 37142655 | |
| Pubmed | ATP6V1B2 AGO2 MYO1D NBEA CEP192 PTPRT PTPN5 YEATS4 PTPRJ LNPEP PRIM2 NUP210 KIF14 PLEKHA1 CACYBP ATP2B1 NCK2 HELLS | 1.26e-07 | 1049 | 134 | 18 | 27880917 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.95e-07 | 219 | 134 | 9 | 31353912 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ATP6V1B2 MYO1D FBL ETFA CIT DDX1 DHX8 IGF2BP1 MDN1 UBR5 NUP210 KIF14 PLEC ATP2B1 SNRNP200 HSPA4 HELLS | 4.60e-07 | 1024 | 134 | 17 | 24711643 |
| Pubmed | GAK ETFA COQ8B SAMHD1 ACTL6A ECPAS NDUFA9 DDX1 IGF2BP1 MDN1 MRPL15 UBR5 NUP210 EHD1 KIF14 DDX60L ATP2B1 SNRNP200 HSPA4 HELLS | 6.88e-07 | 1440 | 134 | 20 | 30833792 | |
| Pubmed | ATP6V1B2 GAK AGO2 FN1 ADGRV1 NDUFA9 UBR5 VCAN DLG2 TNR ATP2B1 | 9.57e-07 | 430 | 134 | 11 | 32581705 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | CFAP47 DPYSL2 FAT4 FN1 COQ8B NBEA SAMHD1 ECPAS KDM4D MDN1 PLXNA4 OR4B1 TNR SNRNP200 | 1.05e-06 | 736 | 134 | 14 | 29676528 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DPYSL2 AGO2 FN1 FBL ACTL6A MCCC2 NDUFA9 DDX1 MDN1 UBR5 PRIM2 SHCBP1 EHD1 DDX60L TAF2 PLEC ATP2B1 SNRNP200 HSPA4 | 1.14e-06 | 1353 | 134 | 19 | 29467282 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | DPYSL2 GAK ETFA SAMHD1 ECPAS PTPN5 IGF2BP1 UBR5 LNPEP SHCBP1 NUP210 PRMT9 CACYBP ATP2B1 SNRNP200 HSPA4 | 1.18e-06 | 974 | 134 | 16 | 28675297 |
| Pubmed | FBL SAMHD1 ECPAS DDX1 IGF2BP1 MDN1 PRIM2 NUP210 PLEC CACYBP SNRNP200 HSPA4 HELLS | 1.23e-06 | 638 | 134 | 13 | 33239621 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ATP6V1B2 VPS11 POP4 ETFA COQ8B ECPAS CIT MDN1 MRPL15 UBR5 PIGX PRIM2 NUP210 ATP2B1 | 1.40e-06 | 754 | 134 | 14 | 33060197 |
| Pubmed | CEP192 ACTL6A NDUFA9 CIT MRPL15 PRIM2 KIF14 TAF2 SNRNP200 EXOSC4 SDHC | 1.52e-06 | 451 | 134 | 11 | 30033366 | |
| Pubmed | DPYSL2 FN1 MYO1D FBL ECPAS DHX8 MDN1 UBR5 NUP210 KIF14 PLEC SNRNP200 HSPA4 | 1.59e-06 | 653 | 134 | 13 | 22586326 | |
| Pubmed | 1.94e-06 | 7 | 134 | 3 | 20058854 | ||
| Pubmed | 2.60e-06 | 156 | 134 | 7 | 29961565 | ||
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 3.09e-06 | 8 | 134 | 3 | 19683999 | |
| Pubmed | Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane. | 3.09e-06 | 8 | 134 | 3 | 21165971 | |
| Pubmed | ATP6V1B2 GAK PIEZO1 ETFA CEP192 MCCC2 NDUFA9 MDN1 MRPL15 UBR5 ERAP2 LNPEP NUP210 PLEKHA1 CACYBP ATP2B1 SNRNP200 HSPA4 HELLS | 4.52e-06 | 1487 | 134 | 19 | 33957083 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DPYSL2 AGO2 POLG ZG16B CEP192 MCCC2 ADGRV1 TECTA ECPAS INTS8 EHD3 AFMID PTPRJ PLXDC2 NUP210 PLEKHA2 SLC35F2 ATP2B1 NCK2 | 4.61e-06 | 1489 | 134 | 19 | 28611215 |
| Pubmed | 4.86e-06 | 323 | 134 | 9 | 24797263 | ||
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 6.58e-06 | 10 | 134 | 3 | 24618850 | |
| Pubmed | 6.58e-06 | 10 | 134 | 3 | 24239741 | ||
| Pubmed | FAT4 AGO2 FBL NUP210L ACTL6A ECPAS YEATS4 UBR5 NUP210 KIF14 DMBT1 CACYBP SNRNP200 | 7.53e-06 | 754 | 134 | 13 | 35906200 | |
| Pubmed | 9.02e-06 | 11 | 134 | 3 | 31776257 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYO1D FBL ETFA SAMHD1 ACTL6A MCCC2 ECPAS DDX1 DHX8 IGF2BP1 MDN1 NUP210 KIF14 CACYBP ATP2B1 SNRNP200 HSPA4 HELLS | 9.65e-06 | 1425 | 134 | 18 | 30948266 |
| Pubmed | DPYSL2 GAK AGO2 FBL ACTL6A MCCC2 YEATS4 KIF14 TAF2 CACYBP SNRNP200 | 9.83e-06 | 549 | 134 | 11 | 38280479 | |
| Pubmed | GAK AGO2 PEX13 ITGA1 ANO10 ECPAS CIT DDX1 MDN1 CLCN5 UBR5 LNPEP NUP210 EHD1 KIF14 ATP2B1 | 1.17e-05 | 1168 | 134 | 16 | 19946888 | |
| Pubmed | MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. | 1.47e-05 | 2 | 134 | 2 | 19561591 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 19297620 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 22777911 | ||
| Pubmed | SUMOylation of EHD3 Modulates Tubulation of the Endocytic Recycling Compartment. | 1.47e-05 | 2 | 134 | 2 | 26226295 | |
| Pubmed | A heart segmental defect in the anterior-posterior axis of a transgenic mutant mouse. | 1.47e-05 | 2 | 134 | 2 | 9188753 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 21204784 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 10380635 | ||
| Pubmed | Deafness and retinal degeneration in a novel USH1C knock-in mouse model. | 1.47e-05 | 2 | 134 | 2 | 20095043 | |
| Pubmed | Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D. | 1.47e-05 | 2 | 134 | 2 | 11138009 | |
| Pubmed | Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction. | 1.47e-05 | 2 | 134 | 2 | 32249312 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 37234154 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 22879593 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 23201264 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 19756140 | ||
| Pubmed | Expression and localization of myosin-1d in the developing nervous system. | 1.47e-05 | 2 | 134 | 2 | 22284616 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 12407180 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 30651325 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15820310 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 12060584 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | AGO2 ETFA MCCC2 DPP3 ECPAS NDUFA9 DDX1 MDN1 PLEC CACYBP SNRNP200 HSPA4 MVD | 1.54e-05 | 807 | 134 | 13 | 30575818 |
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 1.87e-05 | 211 | 134 | 7 | 17314511 | |
| Pubmed | ATP6V1B2 FN1 FBL ECPAS NDUFA9 DDX1 IGF2BP1 MDN1 NUP210 PLEC CACYBP SNRNP200 | 2.00e-05 | 707 | 134 | 12 | 19738201 | |
| Pubmed | 2.17e-05 | 390 | 134 | 9 | 17643375 | ||
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 2.24e-05 | 217 | 134 | 7 | 31685992 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ATP6V1B2 DPYSL2 ACTL6A CIT DDX1 IGF2BP1 MDN1 MRPL15 PLEC ATP2B1 SNRNP200 HSPA4 SDHC | 2.55e-05 | 847 | 134 | 13 | 35235311 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DPYSL2 AGO2 MYO1D ETFA CEP192 MCCC2 ECPAS MAST4 UBR5 ARHGAP12 KIF14 TAF2 PLEC | 2.74e-05 | 853 | 134 | 13 | 28718761 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | AGO2 FBL ETFA SAMHD1 ACTL6A MCCC2 NDUFA9 DDX1 IGF2BP1 MDN1 UBR5 NUP210 SNRNP200 HSPA4 EXOSC4 HELLS | 2.86e-05 | 1257 | 134 | 16 | 37317656 |
| Pubmed | FAT4 MYO1D ETFA ADAM30 NBEA NDUFA9 USP6 MDN1 TAF2 ATP2B1 HELLS | 3.90e-05 | 638 | 134 | 11 | 31182584 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 11802782 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 11960984 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 29874579 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 12437990 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 14578428 | ||
| Pubmed | Early steps in primary cilium assembly require EHD1/EHD3-dependent ciliary vesicle formation. | 4.41e-05 | 3 | 134 | 2 | 25686250 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 16054015 | ||
| Pubmed | CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation. | 4.41e-05 | 3 | 134 | 2 | 19647520 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 9294172 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 12101241 | ||
| Pubmed | An interstitial telomere array proximal to the distal telomere of mouse chromosome 13. | 4.41e-05 | 3 | 134 | 2 | 9166585 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 15691326 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 24019528 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 20639393 | ||
| Pubmed | Probing the S1 specificity pocket of the aminopeptidases that generate antigenic peptides. | 4.41e-05 | 3 | 134 | 2 | 21314638 | |
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 21330445 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 15928608 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 12121420 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 27226355 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 29290964 | ||
| Pubmed | 4.41e-05 | 3 | 134 | 2 | 36716917 | ||
| Pubmed | TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis. | 4.41e-05 | 3 | 134 | 2 | 1696875 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYO1D ETFA SAMHD1 NDUFA9 MDN1 UBR5 NUP210 EHD1 PLEC ATP2B1 HSPA4 | 4.42e-05 | 647 | 134 | 11 | 26618866 |
| Pubmed | FAT4 FN1 WRN NBEA CEP192 MCCC2 IGF2BP1 GTPBP2 UBR5 EHD1 SNRNP200 HELLS | 4.99e-05 | 777 | 134 | 12 | 35844135 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ATP6V1B2 DPYSL2 FBL ETFA SAMHD1 ACTL6A NDUFA9 DDX1 EHD1 CACYBP SNRNP200 | 5.65e-05 | 665 | 134 | 11 | 30457570 |
| Pubmed | Characterization of the zinc-induced Shank3 interactome of mouse synaptosome. | 6.68e-05 | 109 | 134 | 5 | 29111324 | |
| Pubmed | 8.16e-05 | 22 | 134 | 3 | 12963728 | ||
| Pubmed | 8.68e-05 | 363 | 134 | 8 | 25036637 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 24957906 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 16481439 | ||
| Pubmed | Interactions between EHD proteins and Rab11-FIP2: a role for EHD3 in early endosomal transport. | 8.80e-05 | 4 | 134 | 2 | 16251358 | |
| Pubmed | Stereocilin-deficient mice reveal the origin of cochlear waveform distortions. | 8.80e-05 | 4 | 134 | 2 | 18849963 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 10611965 | ||
| Pubmed | C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH? | 8.80e-05 | 4 | 134 | 2 | 16155252 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 27189942 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 14516276 | ||
| Pubmed | Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. | 8.80e-05 | 4 | 134 | 2 | 29212907 | |
| Pubmed | Rabenosyn-5 and EHD1 interact and sequentially regulate protein recycling to the plasma membrane. | 8.80e-05 | 4 | 134 | 2 | 15020713 | |
| Pubmed | Role for a novel Usher protein complex in hair cell synaptic maturation. | 8.80e-05 | 4 | 134 | 2 | 22363448 | |
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 9676579 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 27859053 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 33009420 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 21059598 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 17233914 | ||
| Pubmed | 8.80e-05 | 4 | 134 | 2 | 8717057 | ||
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.71e-07 | 200 | 134 | 8 | 8872d5fa101d413fb43b4231d476878678543035 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.16e-07 | 162 | 134 | 7 | 285e6d553f485fd9f1075c4e1b940da251b5ea35 | |
| ToppCell | Healthy/Control-Plasmablast|Healthy/Control / Disease group and Cell class | 9.96e-07 | 174 | 134 | 7 | 97d19ef3240a1f648c6befaabb9ce45ad469cbce | |
| ToppCell | COVID_vent-Myeloid-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.55e-06 | 186 | 134 | 7 | 63a5cdd3f60681762a218be32db84be8f29b88fd | |
| ToppCell | COVID_vent-Myeloid-Dendritic-cDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.55e-06 | 186 | 134 | 7 | 39457a7b43537f2c3e221f9375c95d4515424d7d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.06e-06 | 194 | 134 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 2.13e-06 | 195 | 134 | 7 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.13e-06 | 195 | 134 | 7 | 578bbb06a5476c08fc3b351cc580c551dfe53ae4 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.20e-06 | 196 | 134 | 7 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.20e-06 | 196 | 134 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | distal-1-Hematologic-Interstitial_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.28e-06 | 197 | 134 | 7 | 9e5df74aeeefa4d928ec07c036aacb549c797f30 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.28e-06 | 197 | 134 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.28e-06 | 197 | 134 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.35e-06 | 198 | 134 | 7 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.35e-06 | 198 | 134 | 7 | 189346c5eb715f3be427bec3b8e067ababb5b475 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.35e-06 | 198 | 134 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.35e-06 | 198 | 134 | 7 | a35b43d38e18c6f8f0cd9015b8e23f71c729f023 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 2.35e-06 | 198 | 134 | 7 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.35e-06 | 198 | 134 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-06 | 199 | 134 | 7 | 0075bcc7d2a5031e76a24cb176e16ac998d846fd | |
| ToppCell | severe_influenza-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 2.43e-06 | 199 | 134 | 7 | b8adbd6ff5e5602259118a69fd7c77e8348a27e4 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.52e-06 | 200 | 134 | 7 | dc8702e3cb4ac8c1a9849fc8abf8777f12d55b0b | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R---L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.52e-06 | 200 | 134 | 7 | d92d51021ab6d78e9c8f89f7c150181004dcbcbd | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.52e-06 | 200 | 134 | 7 | cbbb9044283ff9ab63bbfc24d7a9f006b1372705 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.52e-06 | 200 | 134 | 7 | d0824e6ba32aaaaa398379fdbbc282e890ef154c | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-06 | 200 | 134 | 7 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-06 | 200 | 134 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.52e-06 | 200 | 134 | 7 | a3e36bbeed19431d07bc205f14f4e0f12bd8f730 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.52e-06 | 200 | 134 | 7 | fc061de0db2e8b5ca47f5e2a1e861018e7f1b582 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.37e-05 | 172 | 134 | 6 | 58eaadf12366701103a0d1f133462c9495fedc30 | |
| ToppCell | Healthy/Control-Plasmablast|World / Disease group and Cell class | 1.37e-05 | 172 | 134 | 6 | d3bfcf5d936152b71cd90f955f9331709edd979e | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.37e-05 | 172 | 134 | 6 | 4483073469001770015526303772fd54906c5d68 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 172 | 134 | 6 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 175 | 134 | 6 | 69b59ec58e64644deb7e07f31ef495ef4a6f6276 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 175 | 134 | 6 | 4f7498b5a0ed52c348a5f94bcd41d830ba7954ea | |
| ToppCell | Monocytes-IFN-activated_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.56e-05 | 176 | 134 | 6 | 6a4b403ee3e4dc4f23fbd7a154011e41fd429a9e | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.61e-05 | 177 | 134 | 6 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 183 | 134 | 6 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 183 | 134 | 6 | 84b64cf728629c3af9a8d2ed15b93adf562c54b8 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.01e-05 | 184 | 134 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.07e-05 | 185 | 134 | 6 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 2.13e-05 | 186 | 134 | 6 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-05 | 186 | 134 | 6 | bcb3ac9f9b51346e0a2b0bda96d149b3c11f7883 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 134 | 6 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-05 | 187 | 134 | 6 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 188 | 134 | 6 | f3edcefeef2ce19086032d98b243c02a6d542b38 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-05 | 188 | 134 | 6 | 0792432cd4c564dea1102241ea9884f7ced7658c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 189 | 134 | 6 | 204ab61ae606b2d9be0cb6bf6a83a011740693a8 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 2.33e-05 | 189 | 134 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 189 | 134 | 6 | 13fd07cc408a9486f61a7b2c3a132c52d14b438d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 189 | 134 | 6 | fc88c51ace7d883c01617f3f9b5fab70cc91cc09 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.40e-05 | 190 | 134 | 6 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 2.47e-05 | 191 | 134 | 6 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 2.55e-05 | 192 | 134 | 6 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.62e-05 | 193 | 134 | 6 | d845beb0915a5b4bbd1e8f9b8d9322527a822849 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.62e-05 | 193 | 134 | 6 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.62e-05 | 193 | 134 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.70e-05 | 194 | 134 | 6 | a3e5a15cf6c1361207f661ee15eb634f77daf1cb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.70e-05 | 194 | 134 | 6 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.78e-05 | 195 | 134 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.78e-05 | 195 | 134 | 6 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 195 | 134 | 6 | 62dc745e1aa3e2e58afa16c7bb2cf9b03d4e8105 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.78e-05 | 195 | 134 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.86e-05 | 196 | 134 | 6 | 89ff93cbfbe39fbdf2498e8fdc5d61a0ecb26fc9 | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 2.86e-05 | 196 | 134 | 6 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.86e-05 | 196 | 134 | 6 | 09574bfeb1d3da53b5471cfb0602946d328b3b5c | |
| ToppCell | (7)_Monocyte|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.86e-05 | 196 | 134 | 6 | 0232167559dcd2d86ee8b78017cf5f2a084b2cb7 | |
| ToppCell | (3)_MNP|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.86e-05 | 196 | 134 | 6 | c79403da5443710a6caf035a279e42bc324b27c9 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.94e-05 | 197 | 134 | 6 | e2c53742c7d8d1b63d93843f82330b9e20f1faa6 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 197 | 134 | 6 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.94e-05 | 197 | 134 | 6 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 2.94e-05 | 197 | 134 | 6 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 2.94e-05 | 197 | 134 | 6 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | Influenza_Severe-Classical_Monocyte|World / Disease group and Cell class | 2.94e-05 | 197 | 134 | 6 | e9a01f0fbbeaf6b23bce4603f62053c003848da4 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.94e-05 | 197 | 134 | 6 | ffaf2d7b6aa82008bd64a691b48113626343872c | |
| ToppCell | severe-T/NK_proliferative|World / disease stage, cell group and cell class | 2.94e-05 | 197 | 134 | 6 | 6b7b068b103fd4f6ceda8e01f4dd39eefc3b3633 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 2.94e-05 | 197 | 134 | 6 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.94e-05 | 197 | 134 | 6 | 94e2cc7ec531e58b8ed7e5601fdf8c4bbc3582c8 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-myeloid_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.94e-05 | 197 | 134 | 6 | 9838dbd1623babf8de7e9126a28fe5d3666bce42 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.94e-05 | 197 | 134 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | (7)_MNP|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.94e-05 | 197 | 134 | 6 | 6790346736946984cc80d67668523ba70ab0b380 | |
| ToppCell | distal-Hematologic-Interstitial_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.94e-05 | 197 | 134 | 6 | 3b859c3bbb71858b97ce670bd507e67c377b88eb | |
| ToppCell | BLOOD--(3)_Classical_Mono-2| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.03e-05 | 198 | 134 | 6 | 34c23181c227f65209cde4382248253282f6ac6e | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D231|Adult / Lineage, Cell type, age group and donor | 3.03e-05 | 198 | 134 | 6 | 79a415e19cedde13a88f5043d71557363f102322 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.03e-05 | 198 | 134 | 6 | c79c1738560d78b63dbed5f2f9621dbc1c2363cb | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.03e-05 | 198 | 134 | 6 | 1d1c80569f1e307285ba0ebaf5c72e0b5b538864 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.03e-05 | 198 | 134 | 6 | 880f9817f5145f10f29fc05c5866090433532fe2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.03e-05 | 198 | 134 | 6 | f37578f156e8aed2ce30cfa837ae04dd18de05d0 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.03e-05 | 198 | 134 | 6 | 2e669da80363163b806f23a645474d482797ae5d | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.03e-05 | 198 | 134 | 6 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.03e-05 | 198 | 134 | 6 | 35499a5231818e3432cf69b5c4a58c02f7771db8 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.03e-05 | 198 | 134 | 6 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-05 | 198 | 134 | 6 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 3.11e-05 | 199 | 134 | 6 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | Influenza_Severe-Classical_Monocyte|Influenza_Severe / Disease group and Cell class | 3.11e-05 | 199 | 134 | 6 | 077ace6e0faedb8c701fcb227427204678867237 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.11e-05 | 199 | 134 | 6 | 4fc03377c017209111561789226621d258291481 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 3.11e-05 | 199 | 134 | 6 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_monocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.11e-05 | 199 | 134 | 6 | 7dde5c02fcae64cd2d68f607500f2a46b97851fd | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 3.11e-05 | 199 | 134 | 6 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac|Lung / Manually curated celltypes from each tissue | 3.11e-05 | 199 | 134 | 6 | 1677aaee5b7f5f262e27df5d9f1bdf6e21e3d804 | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.83e-06 | 199 | 134 | 9 | 1055_DN | |
| Disease | endoplasmic reticulum aminopeptidase 2 measurement | 1.90e-05 | 2 | 129 | 2 | EFO_0801566 | |
| Disease | Seizures | 5.09e-05 | 218 | 129 | 7 | C0036572 | |
| Disease | diverticular disease | 8.37e-05 | 236 | 129 | 7 | EFO_0009959 | |
| Disease | cortical thickness | PRTG DPYSL2 NUP210L CPA3 ADGRV1 TM6SF1 USH1C IGF2BP1 GTPBP2 MAST4 PLXDC2 VCAN ARHGAP12 DLEC1 PLEC | 1.09e-04 | 1113 | 129 | 15 | EFO_0004840 |
| Disease | Usher syndrome, type 1A | 1.88e-04 | 5 | 129 | 2 | C2931205 | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 1.88e-04 | 5 | 129 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 1.88e-04 | 5 | 129 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 1.88e-04 | 5 | 129 | 2 | C1848640 | |
| Disease | Usher syndrome type 1 | 1.88e-04 | 5 | 129 | 2 | cv:C1568247 | |
| Disease | cardiovascular disease | 1.89e-04 | 457 | 129 | 9 | EFO_0000319 | |
| Disease | Usher Syndrome, Type I | 2.81e-04 | 6 | 129 | 2 | C1568247 | |
| Disease | QRS duration | 3.49e-04 | 298 | 129 | 7 | EFO_0005055 | |
| Disease | Disorder of eye | 3.50e-04 | 212 | 129 | 6 | C0015397 | |
| Disease | Hereditary retinal dystrophy | 3.93e-04 | 7 | 129 | 2 | C0154860 | |
| Disease | Usher syndrome | 3.93e-04 | 7 | 129 | 2 | cv:C0271097 | |
| Disease | pleckstrin homology domain-containing family A member 1 measurement | 3.93e-04 | 7 | 129 | 2 | EFO_0802873 | |
| Disease | endoplasmic reticulum aminopeptidase 1 measurement | 3.93e-04 | 7 | 129 | 2 | EFO_0008119 | |
| Disease | joint hypermobility measurement | 4.05e-04 | 33 | 129 | 3 | EFO_0007905 | |
| Disease | Nonsyndromic Deafness | 4.47e-04 | 81 | 129 | 4 | C3711374 | |
| Disease | severe pre-eclampsia (is_marker_for) | 5.22e-04 | 8 | 129 | 2 | DOID:13129 (is_marker_for) | |
| Disease | age-related hearing impairment | 5.75e-04 | 324 | 129 | 7 | EFO_0005782 | |
| Disease | lymphocyte count | FN1 MYO1D SGCD PIEZO1 CDH23 PEX13 SAMHD1 ITGA1 TM6SF1 PTPRT SMYD2 RAB36 PTPRJ DDX60L DMBT1 PLEC | 6.68e-04 | 1464 | 129 | 16 | EFO_0004587 |
| Disease | Nephroblastoma | 8.34e-04 | 10 | 129 | 2 | Orphanet_654 | |
| Disease | hearing impairment | 9.17e-04 | 98 | 129 | 4 | C1384666 | |
| Disease | status epilepticus (biomarker_via_orthology) | 9.89e-04 | 100 | 129 | 4 | DOID:1824 (biomarker_via_orthology) | |
| Disease | mortality | 1.00e-03 | 173 | 129 | 5 | EFO_0004352 | |
| Disease | campesterol measurement | 1.02e-03 | 11 | 129 | 2 | EFO_0020008 | |
| Disease | depressive symptom measurement, stressful life event measurement | 1.38e-03 | 50 | 129 | 3 | EFO_0007006, EFO_0007781 | |
| Disease | kynurenic acid measurement | 1.43e-03 | 13 | 129 | 2 | EFO_0010506 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 1.46e-03 | 51 | 129 | 3 | cv:CN043650 | |
| Disease | neuroimaging measurement, brain volume measurement | 1.65e-03 | 286 | 129 | 6 | EFO_0004346, EFO_0006930 | |
| Disease | lymphocyte measurement | 1.77e-03 | 117 | 129 | 4 | EFO_0803546 | |
| Disease | phosphatidylcholine 36:3 measurement | 1.92e-03 | 15 | 129 | 2 | EFO_0010381 | |
| Disease | brain connectivity measurement | 1.94e-03 | 400 | 129 | 7 | EFO_0005210 | |
| Disease | nervousness | 2.19e-03 | 16 | 129 | 2 | NCIT_C74532 | |
| Disease | coronary artery disease | VPS11 FAT4 FN1 SGCD ITGA1 IGF2BP1 MAST4 PTPRJ LNPEP PRIM2 NUP210 DLEC1 ATP2B1 | 2.24e-03 | 1194 | 129 | 13 | EFO_0001645 |
| Disease | reticulocyte measurement | MYO1D PIEZO1 TKTL1 ITGA1 SLFN14 ECPAS EHD3 PTPRJ SLC14A1 KCNQ1 ATP2B1 HSPA4 | 2.29e-03 | 1053 | 129 | 12 | EFO_0010700 |
| Disease | Astrocytosis | 2.47e-03 | 17 | 129 | 2 | C3887640 | |
| Disease | Gliosis | 2.47e-03 | 17 | 129 | 2 | C0017639 | |
| Disease | Global developmental delay | 2.81e-03 | 133 | 129 | 4 | C0557874 | |
| Disease | Abnormality of refraction | 2.87e-03 | 673 | 129 | 9 | HP_0000539 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.09e-03 | 19 | 129 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.09e-03 | 19 | 129 | 2 | C2936783 | |
| Disease | alcohol consumption measurement | SGCD NBEA SAMHD1 DPP3 ADGRV1 CIT MMRN1 IGF2BP1 SLC8A1 MAST4 PTPRJ PLXNA4 CDH18 | 3.15e-03 | 1242 | 129 | 13 | EFO_0007878 |
| Disease | coagulation factor V measurement | 3.42e-03 | 20 | 129 | 2 | EFO_0008087 | |
| Disease | Hereditary hearing loss and deafness | 3.93e-03 | 146 | 129 | 4 | cv:C0236038 | |
| Disease | cognitive function measurement | AGO2 NUP210L PIEZO1 WRN NBEA CEP192 PTPRT IGF2BP1 MAST4 PLXNA4 PLEKHA1 TAF2 TNR SOS1 | 4.08e-03 | 1434 | 129 | 14 | EFO_0008354 |
| Disease | Autosomal Recessive Primary Microcephaly | 4.14e-03 | 22 | 129 | 2 | C3711387 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVDSPIGKVVVSAVY | 471 | Q9Y6N9 | |
| VLIYTSGTTGIPKGV | 226 | Q5FVE4 | |
| PYAGFVLNGIKTVET | 11 | Q8TE69 | |
| PYAGFVLNGIKTVET | 11 | Q96DE9 | |
| PVTLVYQKEGVLASG | 306 | Q8NDM7 | |
| VTQEDLVIGGYLIPK | 421 | Q4G0S4 | |
| IYQGKIPIAGTVVTR | 491 | Q15052 | |
| VIAGTLGQVKPYSSV | 596 | Q6P2P2 | |
| IKIGQDYKGRVSVPT | 91 | P13611 | |
| DGYVLQQGIVKSPLA | 181 | O94805 | |
| IYTVPEVGTVVGGTL | 416 | Q9BX10 | |
| LNIYSVQISEGVPIG | 3406 | Q6V0I7 | |
| YVLQQGIVKSPLAGD | 186 | O96019 | |
| LIGEPSAKYNGTAII | 4161 | Q8WXG9 | |
| SGLGAKIPVTIITGY | 36 | Q5RIA9 | |
| EGIPAGVSIYQVVAI | 901 | Q9H251 | |
| VPGIGAVFQIYIIKD | 1626 | O14578 | |
| TVGDIAQVKYGDLLP | 211 | P20020 | |
| TYAGLQLVVVILPGK | 511 | Q9UKV8 | |
| VVVVGDLYVGKTSLI | 126 | O95755 | |
| PSVYSGVILGIKDNL | 551 | Q75QN2 | |
| VVIVAYGIAPKGTLD | 121 | Q63HM1 | |
| EKVYIATQGPIVSTV | 366 | P54829 | |
| VLGINSITGKEEPLY | 291 | Q9NW15 | |
| VVKAVDPTSGQLYGL | 1256 | Q8TEM1 | |
| QKITYRISGVGIDQP | 81 | P32926 | |
| PVGTAVLYLTGIEVS | 111 | Q6TGC4 | |
| IEQGNTKALAVVYGP | 41 | Q9NPD3 | |
| GGTVSIIPVGEAKTY | 856 | Q15058 | |
| PIKAYAVILTTGEAG | 846 | Q12913 | |
| IGQTKPVVVYRLVTA | 711 | Q9NRZ9 | |
| GVVTVTTIGYGDKVP | 306 | P51787 | |
| GTYPVLIQGETSVGK | 1076 | Q9NU22 | |
| IVQLPTGLTGIKVTY | 91 | P34932 | |
| CAQVPKITLIIGGSY | 431 | Q9HCC0 | |
| RGQVGLVPKNYVVVL | 241 | O43639 | |
| QARKKGTVVYGEPIT | 266 | Q16555 | |
| TVILDNQVTYVPGGK | 221 | Q13201 | |
| LVPTQYVGAIIGKEG | 201 | Q9NZI8 | |
| SDVGVVVYVAPAKSL | 786 | Q5H9U9 | |
| VVYVAPAKSLVGQVA | 791 | Q5H9U9 | |
| SGLGAKIPVTIITGY | 36 | Q8IUF1 | |
| SGLGAKIPVTIITGY | 36 | Q9BRT8 | |
| GKTGAFSIPVIQIVY | 51 | Q92499 | |
| KSGETNPVQIYIGLL | 646 | Q5VYK3 | |
| PVAGGNVKLNYTVLV | 1171 | Q9HCM2 | |
| PIVYGVKTKQIREGV | 291 | Q96RD2 | |
| AAVVAPITTGYTVKI | 61 | Q9HB71 | |
| RKGYSVPKVGTVQVT | 416 | Q7L5A3 | |
| LVTKNLVPGESVYGE | 106 | P22087 | |
| LYGAILPQVVTAGTI | 836 | P54098 | |
| KECGVVIEGVNTPYL | 166 | Q6B0I6 | |
| EPTPGGVKYIIVTQV | 361 | P53602 | |
| IQDKGPIVESYIGFI | 301 | Q9NY33 | |
| TLVSIYAVPEKIGQV | 376 | Q9UIQ6 | |
| TVGYGDVVPVTVAGK | 421 | Q96KK3 | |
| IVVLGNGTIVEKGSY | 831 | Q92887 | |
| DIGPKQTQVGIVQYG | 201 | P56199 | |
| ELGPGNTVQVVAYKL | 131 | Q96ES6 | |
| VKQPVYVVDVSKGIV | 236 | Q16795 | |
| RSGKIIPGQVYIEVE | 6 | Q8IWW6 | |
| SRGAPVSVYQLVVKE | 616 | O14522 | |
| KGGTDLIINSYGPII | 1031 | Q2VWP7 | |
| YKISPGGISQILDLV | 401 | P49643 | |
| DPITGQIIVKGYIDF | 296 | Q9UN74 | |
| PLGVTVQGDVLIVIY | 631 | O14976 | |
| QGVVSPVSYLLQLKG | 56 | Q9UKF2 | |
| QKVYVIGGIATNVRP | 331 | Q9NXS3 | |
| GSTVEDNPLYVLKIG | 146 | P15088 | |
| GNTEVTLVYLGKPLD | 271 | P0C2W1 | |
| LKPGVVYEGQLISIQ | 671 | P02751 | |
| DAVVRGYSIPKGTTV | 386 | Q6VVX0 | |
| KGLKIPQLYQSGVVV | 141 | Q99643 | |
| QLGKYPVIEVLVVTA | 421 | P51795 | |
| SGLGAKIPVTIITGY | 36 | Q5JTY5 | |
| SGLGAKIPVTIITGY | 36 | Q4V339 | |
| ILYGQSIGTVPTVDL | 206 | Q6PCB6 | |
| GTEVAVKIQYPGIAQ | 231 | Q96D53 | |
| EGQGIKTDIPRYIIS | 506 | O15021 | |
| PQYEVVLKGEVISSG | 1736 | Q8TEP8 | |
| YVPESAQVGSAVGKI | 276 | Q13634 | |
| IPTDVLKIVYSVGAQ | 786 | Q6P179 | |
| IPGDNSIYVTKIIDG | 216 | Q15700 | |
| LKTQIPILTYQGGSV | 396 | Q7Z3D6 | |
| KQVVVPAGGSSTIYI | 1391 | Q9Y238 | |
| VGSYQEKVDVVLGPI | 2386 | Q9UGM3 | |
| GKIINTPEVVRVYIG | 241 | Q9H4M9 | |
| GAYIGGTQIIPFVIK | 1066 | Q6ZTR5 | |
| EPTIGDIYNGKVTSI | 261 | Q14562 | |
| GYPVLQSAISTIIGV | 896 | Q3KNS1 | |
| IKGTVLIGVNFVGYS | 861 | Q5VU65 | |
| PIVYGVRTKEIKQGI | 296 | Q8NGH5 | |
| PVYLATVVGNGLIVL | 31 | Q8NGF8 | |
| TQKSLVYGLVGAGVV | 4386 | Q685J3 | |
| KPQVAYKTEIIGGVV | 141 | Q9HB19 | |
| YKTEIIGGVVVHTPI | 146 | Q9HB19 | |
| APDIGLQYKGELTVV | 536 | Q8TDW5 | |
| QVGETSLYGVPIVSL | 76 | P84550 | |
| SLYGVPIVSLVIDGQ | 81 | P84550 | |
| TYKTVSGVNGPLVIL | 46 | P21281 | |
| EKGASGVIIYNVPGT | 121 | Q8WVZ7 | |
| LQTVGGYTGKVCIIP | 496 | P0C7P3 | |
| GVTIQPLKRDYGVQL | 126 | Q9P015 | |
| YVGETQPTGQIKIKR | 456 | Q9Y3Z3 | |
| GTQKYVGPLKVTVQE | 556 | Q6P1X5 | |
| TGKIVAPELYIAVGI | 266 | P13804 | |
| TVKKVVYSLPRVGVG | 2246 | Q8NFP9 | |
| LGSYVKQGTEIVPVG | 266 | Q8N165 | |
| QVVGTPLLVKSGVEY | 401 | Q9H3S1 | |
| IFGYKEIPVLVTQIS | 256 | Q6UX71 | |
| KCPSYVGITGILLQE | 146 | O95707 | |
| NLVGIVVYTPVINGI | 406 | Q96JW4 | |
| QTTGLIPANYVKILG | 321 | Q92968 | |
| VYVGKIGLVISPLIS | 586 | Q14191 | |
| GYGVVLVKPTIFSDL | 541 | Q8NEM2 | |
| GTIISGIQLLIVEYK | 236 | Q8IXU6 | |
| GIYLTNILKTEEGNP | 931 | Q07889 | |
| GKIVNTPEVIRVYIG | 241 | Q9NZN3 | |
| TTRSIAKYPVGIEVG | 166 | P45381 | |
| LSVEVNGYKILIPKG | 381 | O75443 | |
| VITKGFTQLPGDAIY | 591 | O60296 | |
| VTLQPGEYITKVFVA | 111 | Q96DA0 | |
| ELLGTYIKQGTEIVP | 461 | Q8TDR2 | |
| YIKQGTEIVPVGEAL | 466 | Q8TDR2 | |
| GAVQQYIRTIGKLEP | 406 | Q9H270 | |
| SVYKNVILQVPVGLT | 211 | Q8TBF5 | |
| EKVKQVTPLSVGVYV | 111 | Q13156 | |
| VTPLSVGVYVKVFGI | 116 | Q13156 | |
| LTQLITGPKAVEAYG | 121 | Q92629 | |
| IGSGIFVSPKGVLIY | 51 | Q9UM01 | |
| QTGLKPGEEYIVNVV | 471 | Q92752 | |
| AQAATGYVIDPIKGL | 4106 | Q15149 | |
| ELLKSIPVGVGQIYG | 221 | Q13336 | |
| VIIKGTQVYSPEKGR | 826 | O75643 | |
| QPIDVTVTLKLGGYE | 2206 | Q92508 | |
| VKGVTIVKPIVYGNV | 16 | O95619 | |
| KKQVSYRTDIVGGVP | 136 | Q9HB21 | |
| PNVIVTYKGTLAEVR | 211 | Q9NRG4 | |
| KVTVIGAGITVYEAL | 476 | P51854 | |
| ITVIKLDGTTPVRYG | 721 | P35125 | |
| PVGKVLKVDGAYVAV | 666 | O95071 | |
| VVVFVPGNIVGKYGT | 151 | Q9BZW5 | |
| ARGNVIVPYKTIEGT | 566 | P32418 | |
| FIGEVVVSVNPYKLL | 41 | O94832 | |
| VIQGIISPVNDTYGK | 41 | Q96T66 |